Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men

Clinical trial NCT00287833 · COMPLETED

Trial details

NCT number: NCT00287833
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-01-01
Primary completion: 2007-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.